A Which? consumer review and expert panel challenge menopause marketing claims, finding most specialized supplements offer no more benefit than multivitamins.
Which? has announced a free virtual event on midlife and menopause scheduled for October 13, combining an NHS GP, a consultant dermatologist and a public health nutritionist to scrutinise menopause marketing and skincare claims.
Historically, the standard medical consensus treated menopause strictly as a reproductive transition marked by the cessation of periods, focusing almost exclusively on severe acute symptoms. Clinical guidelines provided clear protocols for prescribing systemic hormones when hot flushes became unmanageable, but they offered little support for the gradual, interconnected changes women experienced leading up to that point. This narrow clinical focus created a significant gap in care for women navigating the decade of perimenopause. Medical appointments rarely left time to discuss shifting body composition, changes in skin elasticity, or the broader physical realities of aging.
Because clinical protocols failed to address the full midlife picture, the commercial wellness industry quickly moved in to fill the void. A new, commercially driven standard of care emerged, one that treated every physical shift as a condition requiring a consumer purchase. Women seeking practical context about their changing bodies found themselves navigating a landscape dominated by anti-aging pressure and aggressive product marketing. Instead of receiving clear medical explanations about how fluctuating estrogen levels affect collagen production or metabolic rate, women were directed toward unregulated supplements and untested skincare routines.
This separation of medical care from lifestyle reality allowed an entire category of specialized menopause products to flourish without clinical scrutiny. The prevailing consensus effectively accepted that women would manage their own non-acute symptoms using over-the-counter wellness products. This dynamic assumed that a product labeled for midlife women was inherently necessary, safe, and effective. The burden of proof was shifted onto the consumer, requiring women to decipher complex biochemical claims and ingredient lists without foundational physiological knowledge.
The beauty and skincare industries capitalized on this lack of clinical support by framing natural hormonal shifts in skin structure as problems to be fixed. Marketing campaigns heavily promoted proprietary creams and aesthetic interventions, mixing genuine changes in skin thickness with intense youth-focused pressure. Women looking for realistic information on skin, hair and aesthetic aging were met with broad, unsupported promises rather than factual dermatological guidance.
When medical consensus focuses solely on reproductive cessation, it dismisses the profound ways that shifting biology affects a woman's daily life. Women experiencing changes in energy levels, sleep quality, and physical stamina were often told that these were just normal parts of aging to be tolerated. This dismissive clinical attitude eroded confidence, making women feel that their legitimate health concerns were frivolous. The lack of structured medical support during this transition period left many feeling unsupported by the healthcare system they had relied on for decades.
The wellness industry recognized this vulnerability and targeted it with precision. Brands formulated campaigns that preyed on the fear of aging, positioning their products as the only defense against a deteriorating body. This approach further complicated the emotional landscape of midlife, intertwining physical health with intense aesthetic pressure. Women were no longer just managing a physiological transition; they were fighting a continuous battle against an idealized version of youth.
Beyond the financial cost of testing endless product combinations, this relentless marketing takes a profound emotional toll. Being told constantly that your changing body is a problem to be solved creates an environment of symptom panic. Women entering this transition deserve to understand their biology without the overarching pressure to fix every natural fluctuation. True confidence in midlife comes from clear information, not from a medicine cabinet full of unverified promises.
Simultaneously, the dietary supplement market expanded rapidly, offering complex blends of vitamins and botanicals positioned as comprehensive solutions for the hormonal transition. The medical community largely stood back from this trend, neither recommending these products in formal guidelines nor aggressively challenging them. This hands-off approach from clinicians allowed marketing materials to serve as primary educational resources for millions of women. Health content began treating every midlife concern as a supplement or weight-loss opportunity.
Women noticing changes in their strength, body composition and metabolism were frequently steered away from sustainable movement and nutrition. Instead, they were pushed toward expensive botanical blends with questionable efficacy. The old paradigm left women isolated, trying to manage a major physiological transition with unverified products while true medical support remained restricted to narrow symptom thresholds.
The upcoming Which? discussion aims to challenge this commercialized standard by bringing rigorous medical and nutritional scrutiny to midlife wellness products. Scheduled to feature an NHS GP, a consultant dermatologist, and a public health nutritionist, the event explicitly puts menopause marketing alongside clinical evidence. Hosted by Which? presenter Erica McKoy, the discussion covers practical responses to hormonal shifts, gut health, and bone density. By prioritizing attendee questions, the panel provides a consumer-focused counterweight to the relentless supplement hype that dominates the industry.
Ahead of this scheduled event, separate reporting on a Which? consumer review offers a stark look at the actual efficacy of these heavily promoted products. This extensive analysis evaluated dozens of formulations to determine if they hold up against clinical standards. The findings directly challenge the persistent narrative that specialized commercial products are a mandatory part of the hormonal transition.
The consumer review and associated expert reporting produced several critical findings regarding the menopause supplement market:
The Which? analysis specifically noted that none of the 26 assessed products contained nutrient combinations at scientifically proven doses. This finding strikes at the core of the supplement industry's marketing strategy. Brands routinely highlight long lists of active ingredients to create a perception of comprehensive efficacy. However, the sheer presence of an ingredient does not guarantee it reaches a therapeutic threshold capable of relieving symptoms.
This practice of underdosing active compounds while promoting their inclusion allows companies to make broad health associations without delivering clinical results. Consumers pay premium prices for specialized formulations that, according to the review, offer no overall advantage over standard multivitamins. The discrepancy between marketing claims and actual formulation strength highlights the urgent need for critical consumer awareness. Women must be able to trust that the products they purchase are formulated to meet genuine biological needs.
These findings highlight the profound difference between a compelling marketing narrative and reproducible clinical results. The placebo comparison in the red clover trial is particularly illustrative. When a biologically inactive placebo outperforms a heavily marketed botanical ingredient in reducing hot flushes, it demonstrates the necessity of rigorous clinical trials. Without such data, women are left guessing whether a product's perceived benefits are pharmacological or simply the result of natural symptom fluctuation over time.
The findings on black cohosh further highlight the strict need for safety transparency. Rare cases of liver damage present a concrete risk that is rarely advertised on the front of a supplement bottle. This gap between marketing promises and actual safety profiles shows why regulatory scrutiny is necessary. As women navigate the transition, distinguishing between tested medical interventions and unverified consumer products becomes a matter of physical safety.
The contrast between regulated therapies and wellness products is particularly stark when considering long-term health outcomes. Hormone replacement therapy undergoes rigorous testing to establish exact dosing protocols, safety profiles, and expected results for symptom management. Commercial wellness items simply do not face this level of clinical demand before reaching the shelves. This regulatory difference means that women relying on over-the-counter botanical blends may be missing out on proven interventions that provide measurable, documented relief.
Finding reliable guidance through perimenopause, menopause and hormonal change articles requires looking past the branding to examine the underlying science. The Which? consumer coverage explicitly advises women to scrutinize the evidence and safety of products rather than relying on menopause-focused branding alone. It reinforces the reality that there is no universal, over-the-counter regimen capable of managing the varied changes women experience during midlife.
The scrutiny of these wellness products will drive a necessary shift in clinical practice, compelling healthcare providers to actively guide patients away from commercial hype and toward evidence-backed treatments during their hormonal transition.
Once you move past the commercial hype surrounding midlife skincare and wellness products, identifying evidence-based strategies for your shifting physiology is the required next step. Refemina actively counters health content that treats every problem as a supplement, hormone or weight-loss opportunity, translating credible evidence into clear adult guidance so you can manage your wellbeing with confidence.
Follow Refemina for research-led insights on menopause, strength, metabolism, nutrition, skin, intimacy and confidence through midlife. New articles turn complex topics into clear, useful context.
Keep learning about the changes that shape energy, strength, confidence and wellbeing through midlife.
Explore Resources